CYP2E1 and Hepatic steatosis: In addition, adeno-associated virus 9 (AAV9)-shRNAs or CMZ, an inhibitor of CYP2E1, was used to downregulate Cyp2e1 (Supplementary information, Fig. S3a, b), and the effect on liver steatosis was evaluated.